Vernakalant hydrochloride
CAS: 748810-28-8
Ref. 3D-YEB81028
1mg | Descontinuado | ||
5mg | Descontinuado | ||
10mg | Descontinuado | ||
25mg | Descontinuado | ||
50mg | Descontinuado |
Informação sobre produto
- (1R,2R)-2-((3R)-Hydroxypyrrolidinyl)-1-(3,4-dimethoxyphenethoxy)cyclohexane monohydrochloride
- (1R,2R)-2-((3R)-Hydroxypyrrolidinyl)-1-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexane monohydrochloride
- (3R)-1-[(1R,2R)-2-[2-(3,4-Dimethoxyphenyl)ethoxy]cyclohexyl]-3-pyrrolidinol monohydrochloride
- 3-Pyrrolidinol, 1-[(1R,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl]-, hydrochloride (1:1), (3R)-
- 3-Pyrrolidinol, 1-[(1R,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl]-, hydrochloride, (3R)-
- Brinavess
- Rsd-1235
Vernakalant hydrochloride is a compound that acts as a phosphatase inhibitor. It has been used in research studies to investigate the effects of phosphatase inhibition on various cellular processes. Vernakalant hydrochloride has also been studied for its potential use as an antidote for ethyl carbamate poisoning, as it can inhibit the metabolism of ethyl carbamate and prevent its toxic effects. Additionally, this compound has been shown to have antimicrobial properties and may be effective against certain pathogens. It is important to note that vernakalant hydrochloride is primarily used in research settings and is not approved for therapeutic use in humans or animals.